foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Inv€$table CEO Pitch Series: Emma Sceats, CEO of 2...

Straight from the Inv€$table CEO Pitch Breakfast hosted by K&L Gates on Tue...

Read More

Top Tips For Successful Private Fund Raise

Anker Lundemose, CEO of MISSION Therapeutics talks to Biotech and Money abo...

Read More

ISSUE 9, 2016 Drugs & Dealers Magazine Released

Biotech and Money are pleased to announce the release of the latest Drugs &...

Read More

Creating a substantial franchise in the allergy se...

We recently spoke to Manuel Llobet of Allergy Therapeutics about franchisin...

Read More

4 things I learned from Eddy Littler, CEO of Domai...

Biotech and Money recently had the opportunity to catch up with Eddy Little...

Read More

Five things we learned from Rockefeller President ...

Biotech and Money recently caught up with Marc Tessier-Lavigne, president o...

Read More

The Californian biotech who brought a $100m IPO to...

Verseon was founded in 2002. Its proprietary drug discovery platform, devel...

Read More

Using conformational design to target a $9bn thera...

C4X Discovery, a Manchester-based, AIM-listed Company which uses an NMR-bas...

Read More

Investing in making the undruggable druggable

PhoreMost Ltd, a biopharmaceutical company focused on increasing the divers...

Read More

Succeeding at the hybrid business model: Domainex

 Dr Eddy Littler became the Chief Executive Officer of Domainex in May 2008...

Read More

Add Your Response